Kyndryl Shares Plunge 55% Amid Accounting Review and Executive Departures

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Kyndryl shares dropped 55% after accounting review revealed cash management issues. CFO and General Counsel departed amid SEC inquiry and fraud lawsuit filing.

Kyndryl Shares Plunge 55% Amid Accounting Review and Executive Departures

Kyndryl Holdings Inc. (NYSE:KD) experienced a significant decline in share price following the company's announcement of delayed financial reporting for the third quarter of 2026. The technology infrastructure company disclosed that its accounting review had uncovered issues related to cash management practices and adjusted free cash flow metrics, prompting the company to postpone the release of its Q3 financial statements.

The accounting irregularities triggered executive changes within the organization, with both the Chief Financial Officer and General Counsel departing their positions. The departures came after the Securities and Exchange Commission issued document requests to the company, signaling a regulatory inquiry into the disclosed issues. These developments raised concerns among investors regarding the accuracy of previously reported financial information.

In response to the accounting disclosures, a securities fraud class action lawsuit has been filed against Kyndryl and certain senior executives, alleging violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The legal action seeks to represent shareholders who purchased company securities during the period when the accounting issues were not publicly disclosed. Legal representatives are currently notifying affected investors of the pending litigation.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 21

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

Immutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit

Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.

IMMP